1. Home
  2. GROW vs NEPH Comparison

GROW vs NEPH Comparison

Compare GROW & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Global Investors Inc.

GROW

U.S. Global Investors Inc.

HOLD

Current Price

$3.19

Market Cap

31.3M

Sector

Finance

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$3.07

Market Cap

31.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GROW
NEPH
Founded
1968
1997
Country
United States
United States
Employees
N/A
31
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
31.0M
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
GROW
NEPH
Price
$3.19
$3.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
16.3K
53.0K
Earning Date
05-07-2026
03-12-2026
Dividend Yield
2.85%
N/A
EPS Growth
N/A
106.67
EPS
0.05
0.10
Revenue
$23,850,609.00
$14,162,000.00
Revenue This Year
N/A
$12.82
Revenue Next Year
N/A
$10.02
P/E Ratio
$63.80
$30.70
Revenue Growth
N/A
N/A
52 Week Low
$2.05
$1.49
52 Week High
$3.65
$6.42

Technical Indicators

Market Signals
Indicator
GROW
NEPH
Relative Strength Index (RSI) 50.84 31.46
Support Level $3.10 $2.89
Resistance Level $3.43 $4.93
Average True Range (ATR) 0.09 0.25
MACD -0.03 -0.09
Stochastic Oscillator 34.46 13.98

Price Performance

Historical Comparison
GROW
NEPH

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: